{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T12:35:32Z","timestamp":1761395732067},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Medicine and Surgery"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.amsu.2020.04.010","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T13:02:58Z","timestamp":1588165378000},"page":"85-88","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Prophylactic effects of biogenic selenium nanoparticles on acute toxoplasmosis: An in vivo study"],"prefix":"10.1097","volume":"54","author":[{"given":"Mojtaba","family":"Shakibaie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Ezzatkhah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esraa","family":"Gabal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebrahim","family":"Badparva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sareh","family":"Jahanbakhsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Mahmoudvand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.amsu.2020.04.010_bib1","first-page":"634","article-title":"Toxoplasmosis-a waterborne zoonosis. Vet Parasitol. 126: 57-72. Hill D, Dubey J. 2002. Toxoplasma gondii: transmission, diagnosis and prevention","volume":"8","author":"Dubey","year":"2004","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.amsu.2020.04.010_bib2","first-page":"16","article-title":"Toxoplasmosis: epidemiology, diagnosis, treatment","volume":"60","author":"Khryanin","year":"2015","journal-title":"Antibiot. Khimioter."},{"key":"10.1016\/j.amsu.2020.04.010_bib3","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/rheumatology\/kev115","article-title":"Toxoplasmosis in immunosuppressed patients","volume":"54","author":"Lewis","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.amsu.2020.04.010_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/B978-0-444-53490-3.00008-X","article-title":"Toxoplasmosis","volume":"114","author":"Halonen","year":"2013","journal-title":"Handb. Clin. Neurol."},{"issue":"1","key":"10.1016\/j.amsu.2020.04.010_bib5","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10753-015-0262-6","article-title":"Toxoplasma gondii infection promotes neuroinflammation through cytokine networks and induced hyper algesia in BALB\/c mice","volume":"39","author":"Mahmoudvand","year":"2016","journal-title":"Inflammation"},{"key":"10.1016\/j.amsu.2020.04.010_bib6","first-page":"177","article-title":"Acetylcholinesterase inhibitor improves learning and memory impairment induced by Toxoplasma gondii infection","volume":"11","author":"Mahmoudvand","year":"2016","journal-title":"Iran. J. Parasitol."},{"key":"10.1016\/j.amsu.2020.04.010_bib7","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.biopha.2016.05.041","article-title":"Human toxoplasmosis-searching for novel chemotherapeutics","volume":"82","author":"Antczak","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.amsu.2020.04.010_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fmicb.2017.00025","article-title":"A systematic review of in vitro and in vivo activities of anti-Toxoplasma drugs and compounds (2006-2016)","volume":"8","author":"Montazeri","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.amsu.2020.04.010_bib9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1042\/BA20100042","article-title":"Biosynthesis and recovery of selenium nanoparticles and the effects on matrix metalloproteinase-2 expression","volume":"56","author":"Shakibaie","year":"2010","journal-title":"Biotechnol. Appl. Biochem."},{"issue":"6","key":"10.1016\/j.amsu.2020.04.010_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience Research reporting: the ARRIVE Guidelines for reporting animal Research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol."},{"issue":"4","key":"10.1016\/j.amsu.2020.04.010_bib11","first-page":"625","article-title":"Efficacy of the bunium persicum (boiss) essential oil against acute toxoplasmosis in mice model","volume":"10","author":"Tavakoli Kareshk","year":"2015","journal-title":"ranian J of Parasitol"},{"issue":"1","key":"10.1016\/j.amsu.2020.04.010_bib12","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1099\/jmm.0.001111","article-title":"Biogenic selenium nanoparticles target chronic toxoplasmosis with minimal cytotoxicity in a mouse model","volume":"64","author":"Keyhani","year":"2020","journal-title":"J. Med. Microbiol."},{"issue":"5","key":"10.1016\/j.amsu.2020.04.010_bib13","article-title":"S100a9 knockdown decreases the memory impairment and the neuropathology in Tg2576, AD animal model","volume":"21","author":"Ha","year":"2010","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.amsu.2020.04.010_bib14","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00281-012-0339-3","article-title":"Immune response and immunopathology during toxoplasmosis","volume":"34","author":"Dupont","year":"2012","journal-title":"Semin. Immunopathol."},{"issue":"12","key":"10.1016\/j.amsu.2020.04.010_bib15","doi-asserted-by":"crossref","first-page":"10165","DOI":"10.1166\/jnn.2015.11692","article-title":"Adjuvant effect of biogenic selenium nanoparticles improves the immune responses and survival of mice receiving 4T1 cell antigens as vaccine in breast cancer murine model","volume":"15","author":"Yazdi","year":"2015","journal-title":"J. Nanosci. Nanotechnol."},{"issue":"2","key":"10.1016\/j.amsu.2020.04.010_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15171\/ijb.1056","article-title":"Th1 immune response induction by biogenic selenium nanoparticles in mice with breast cancer: preliminary vaccine model","volume":"13","author":"Yazdi","year":"2015","journal-title":"Iran. J. Biotechnol."},{"key":"10.1016\/j.amsu.2020.04.010_bib17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jtemb.2012.11.002","article-title":"Efficacy of biogenic selenium nanoparticles against Leishmania major: in vitro and in vivo studies","volume":"27","author":"Beheshti","year":"2013","journal-title":"J. Trace Elem. Med. Biol."},{"key":"10.1016\/j.amsu.2020.04.010_bib18","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ijsu.2014.03.017","article-title":"Scolicidal effects of biogenic selenium nanoparticles against protoscolices of hydatid cysts.","volume":"12","author":"Mahmoudvand","year":"2014","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.amsu.2020.04.010_bib19","first-page":"1553","article-title":"Selenium nanoparticles inhibit","volume":"6","author":"Tran","year":"2011","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.amsu.2020.04.010_bib20","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s10620-008-0361-4","article-title":"Antibacterial action of selenium-enriched probiotics against pathogenic","volume":"54","author":"Yang","year":"2009","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.amsu.2020.04.010_bib21","series-title":"Essential of Toxicology","author":"Loomis","year":"1968"}],"container-title":["Annals of Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2049080120300431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2049080120300431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T11:08:36Z","timestamp":1677064116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2049080120300431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":21,"alternative-id":["S2049080120300431"],"URL":"https:\/\/doi.org\/10.1016\/j.amsu.2020.04.010","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prophylactic effects of biogenic selenium nanoparticles on acute toxoplasmosis: An in vivo study","name":"articletitle","label":"Article Title"},{"value":"Annals of Medicine and Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amsu.2020.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.","name":"copyright","label":"Copyright"}]}}